Drug Analyst I Cardiovascular/Metabolic
+1 year(s) experience
Pippa previously gained a BSc in Neuroscience at Glasgow and an MSc in Biotechnology at Imperial College London. Through her studies and internships, she possesses a comprehensive understanding of human biology, specializing in neuroscience, CRISPR, and stem cells. As her dissertation investigated the microbiome, Pippa appreciates the importance of diet and microbe interactions to metabolic processing and human health, and the potential of this field to impact the drug market in the near future.
By Pippa Nutkins 05 Nov 2018
Depression affects approximately 1 in 6 Americans, with 10 – 30% of depression patients becoming treatment-resistant. Find out what the pipeline looks like for depression and what the emerging strategies in this area are. This data-packed whitepaper from Informa Pharma Intelligence can now be downloaded – free.
By Pippa Nutkins 02 Mar 2018
We investigated the latest research trends and pharmacological interventions for the escalating global obesity epidemic. The argument that eating disorders and obesity are similarly manifested in genetic, metabolic and psychological origins could be an important consideration for drug development in these two complex indications.